Surgery Partners (Surgery Partners) Cash And Cash Equivalents : $185 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners Cash And Cash Equivalents?

Surgery Partners's quarterly cash and cash equivalents declined from Sep. 2023 ($236.00 Mil) to Dec. 2023 ($195.90 Mil) but then stayed the same from Dec. 2023 ($195.90 Mil) to Mar. 2024 ($185.20 Mil).

Surgery Partners's annual cash and cash equivalents declined from Dec. 2021 ($389.90 Mil) to Dec. 2022 ($282.90 Mil) and declined from Dec. 2022 ($282.90 Mil) to Dec. 2023 ($195.90 Mil).

Surgery Partners Cash And Cash Equivalents Historical Data

The historical data trend for Surgery Partners's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgery Partners Cash And Cash Equivalents Chart

Surgery Partners Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

92.70

317.90

389.90

282.90

195.90

Surgery Partners Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															245.50	177.40	236.00	195.90	185.20

Surgery Partners Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Surgery Partners (NAS:SGRY) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Surgery Partners Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Surgery Partners's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgery Partners (Surgery Partners) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027

Website

https://www.surgerypartners.com

Surgery Partners Inc is one of the few remaining independent ambulatory surgery center operators in the U.S. with national scale. The firm operates surgical facilities in approximately 30 states in partnership with physician groups and larger local healthcare systems. While surgical procedures drive a majority of the firm's revenue, the company also operates a clinical lab, urgent care facilities, and a handful of physician practices to provide additional healthcare services within the communities it serves. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.

Executives

Bain Capital Investors Llc	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt	director, officer: Chief Executive Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
T. Devin O'reilly	director, 10 percent owner	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix	director, 10 percent owner
Andrew T. Kaplan	director	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Jason Eric Evans	officer: EVP & Chief Operating Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Harrison R. Bane	officer: American Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
David T Doherty	officer: Chief Financial Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bradley R. Owens	officer: National Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Danielle Burkhalter	officer: Chief Human Resources Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo	officer: President, Atlantic Group	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock	officer: Sr. VP, Gen Couns. & Sec.	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham	officer: Chief Strategy Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bain Capital Fund Xi, L.p.	director, 10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Xi, L.p.	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116